1- American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee.
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med
1992; 20:864–874.
2- Watson RS, Carcillo JA, Linde-Zwirble WT, et al. The epidemiology of severe sepsis in children in the United
States. Am J Respir Crit Care Med 2003;167:695–701.
3- Alberti C, Brun-Buisson C, Goodman SV, et al. Influence of systemic inflammatory response syndrome and
sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 2003; 168:77–84.
4- Mandell, Douglas, Bennets. Principles and practice of Infectious Disease. 6th ed. Philadelphia: Churchill
Livingstone; 2005.
5- Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response
syndrome. Clin Chim Acta 2005; 351(1-2): 17-29.
6- Shibata K, Funada H. The epidemiology of SIRS.Sepsis in JapanNippon Rinsho 2004; 62(12):2184-8.
7- Sun D, Aikawa N. The natural history of the systemic inflammatory response syndrome and the evaluation of
SIRS criteria as a predictor of severity in patients hospitalized through emergency servicesKeio. J Med 1999;
48(1):28-37.
8- Shapiro NI, Howell M, Talmor D. A blueprint for a sepsis protocol. Acad Emerg Med 2005 Apr; 12(4): 352-9.